Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy

National Taiwan University

Status: Completed

Conditions: Head and Neck Cancers Patients

Treatments: Diagnostic Test: Serum levels of immunologic profiles

Study type: Observational

Funder types: Other

Identifiers

NCT03325036

201706046RINC

Details and patient eligibility

About

The purpose of the study is to investigate the clinical usefulness of serum levels of immunologic profiles including pro/anti-inflammatory interleukins, other detectable serum biomarkers including transforming growth factor b1 (TGFb1) or soluble major histocompatibility complex Class I chain-related peptide A (sMICA), and leukocyte subpopulations in head and neck cancers patients receiving curative radiotherapy, as prognostic biomarkers for disease recurrence and survival.

Enrollment: 60 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with head and neck cancer receiving curative radiotherapy in NTUH radiation therapy department.

Exclusion criteria

• Patients with head and neck cancer NOT receiving curative radiotherapy in NTUH radiation therapy department.